pCMV_BE4max_3xHA Citations (4)
Originally described in: Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction.Koblan LW, Doman JL, Wilson C, Levy JM, Tay T, Newby GA, Maianti JP, Raguram A, Liu DR Nat Biotechnol. 2018 May 29. pii: nbt.4172. doi: 10.1038/nbt.4172. PubMed Journal
Articles Citing pCMV_BE4max_3xHA
| Articles |
|---|
| Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6. Fuchsbauer O, Swuec P, Zimberger C, Amigues B, Levesque S, Agudelo D, Duringer A, Chaves-Sanjuan A, Spinelli S, Rousseau GM, Velimirovic M, Bolognesi M, Roussel A, Cambillau C, Moineau S, Doyon Y, Goulet A. Mol Cell. 2019 Dec 19;76(6):922-937.e7. doi: 10.1016/j.molcel.2019.09.012. Epub 2019 Oct 8. PubMed |
Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9.
Agudelo D, Carter S, Velimirovic M, Duringer A, Rivest JF, Levesque S, Loehr J, Mouchiroud M, Cyr D, Waters PJ, Laplante M, Moineau S, Goulet A, Doyon Y.
Genome Res. 2020 Jan;30(1):107-117. doi: 10.1101/gr.255414.119. Epub 2020 Jan 3.
PubMed
Associated Plasmids |
| Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base Editing. Yang L, Wang L, Huo Y, Chen X, Yin S, Hu Y, Zhang X, Zheng R, Geng H, Han H, Ma X, Liu M, Li H, Yu W, Liu M, Wang J, Li D. Mol Ther. 2020 Jul 8;28(7):1673-1683. doi: 10.1016/j.ymthe.2020.05.001. Epub 2020 May 7. PubMed |
| Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery. Kweon J, Jang AH, Kwon E, Kim U, Shin HR, See J, Jang G, Lee C, Koo T, Kim S, Kim Y. Exp Mol Med. 2023 Feb;55(2):377-384. doi: 10.1038/s12276-023-00938-w. Epub 2023 Feb 1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.